Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci

被引:10
|
作者
Jakobovits, A [1 ]
机构
[1] Abgenix Inc, Discovery Res, Fremont, CA 94555 USA
关键词
immunoglobulin; transgene; yeast artificial chromosome; ES cells; B cell development; antibody therapy;
D O I
10.1016/S0169-409X(97)00092-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to produce highly specific fully human monoclonal antibodies to human antigens has potential significant applications to human therapy. This review describes the creation of novel mouse strains engineered to produce a diverse repertoire of fully human antibodies in the absence of mouse antibodies. These mouse strains have been generated by introducing megabase-sized human immunoglobulin loci, containing the majority of the human antibody gene repertoire, in nearly germline configuration, into mice deficient in mouse antibody production. The mice produce high levels of human IgM kappa and IgG kappa antibodies with a diverse adult-like repertoire. Upon immunization with multiple human antigens the mice generate high infinity, antigen-specific fully human monoclonal antibodies with neutralization activity. Comparison of these mice to other strains containing limited human antibody gene repertoire underscores the importance of the large number of variable genes for faithful reproduction of functional and diverse human antibody response in mice. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [21] Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma
    Kim, JC
    Kim, WS
    Ryu, JS
    Oh, SJ
    Lee, DH
    Koo, KH
    Roh, SA
    Kin, HC
    Yu, CS
    Kang, GH
    Bodmer, WF
    CANCER RESEARCH, 2000, 60 (17) : 4825 - 4829
  • [22] Correction: Corrigendum: Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
    Kenneth Smith
    Lori Garman
    Jens Wrammert
    Nai-Ying Zheng
    J Donald Capra
    Rafi Ahmed
    Patrick C Wilson
    Nature Protocols, 2014, 9 : 2903 - 2903
  • [23] Development of an alternative method for the identification and production of antigen-specific monoclonal antibodies
    Byrne-Steele, Miranda
    Sanders, Catherine
    Yang, Qunying
    Pan, Wenjing
    Wang, Chunlin
    Han, Jian
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [24] Detecting and monitoring human leukocyte antigen-specific antibodies
    Zachary, Andrea A.
    Leffell, M. Sue
    HUMAN IMMUNOLOGY, 2008, 69 (10) : 591 - 604
  • [25] Protocol for isolating antigen-specific monoclonal antibodies from immunized mice utilizing the Beacon platform
    Fu, Meilan
    Wang, Xiangwei
    Tang, Shubing
    Bai, Shimeng
    Ding, Longfei
    Hu, Yangyang
    Cao, Kangli
    Yang, Tianhan
    Zhao, Chen
    Zhang, Xiaoyan
    Xu, Jianqing
    STAR PROTOCOLS, 2024, 5 (04):
  • [26] Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci
    He, YX
    Honnen, WJ
    Krachmarov, CP
    Burkhart, M
    Kayman, SC
    Corvalan, J
    Pinter, A
    JOURNAL OF IMMUNOLOGY, 2002, 169 (01): : 595 - 605
  • [27] Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci
    Shibata, Y
    Hosogi, Y
    Hayakawa, M
    Hori, N
    Kamada, M
    Abiko, Y
    VACCINE, 2005, 23 (29) : 3850 - 3856
  • [28] Antigen-specific antibody production of human B cells in NOG mice reconstituted with the human immune system
    Ito, R.
    Shiina, M.
    Saito, Y.
    Tokuda, Y.
    Kametani, Y.
    Habu, S.
    HUMANIZED MICE, 2008, 324 : 95 - 107
  • [29] Production of antigen-specific human IgGs by in vitro immunization
    A. Wijkhuisen
    A. Savatier
    N. Cordeiro
    M. Léonetti
    BMC Biotechnology, 16
  • [30] Production of antigen-specific human IgGs by in vitro immunization
    Wijkhuisen, A.
    Savatier, A.
    Cordeiro, N.
    Leonetti, M.
    BMC BIOTECHNOLOGY, 2016, 16